Table 2.
Comparison between the indolent KD vs. resolved KD groups
| Indolent KD (n = 8) | Resolved KD (n = 63) | p value | |||
|---|---|---|---|---|---|
| Age, months; mean (SD) | 16.3 | (15.9) | 28.4 | (23.1) | 0.16 |
| Male, n (%) | 4.0 | (50) | 32.0 | (50.8) | 0.97 |
| Incomplete KD, n (%) | 6.0 | (75) | 36.0 | (57.1) | 0.33 |
| Duration of fever, days; mean (SD) | 4.6 | (1.2) | 4.7 | (1.3) | 0.93 |
| No. of KD criteria, mean (SD) | 3.0 | (0.9) | 3.8 | (0.9) | 0.04* |
| WBC, × 103/μL; mean (SD) | 12.1 | (3.4) | 12.5 | (4.7) | 0.81 |
| Neutrophils, %; mean (SD) | 53.5 | (13.3) | 54.6 | (16.6) | 0.86 |
| Hb, g/L; mean (SD) | 10.4 | (0.9) | 11.6 | (1.2) | 0.01* |
| Hct, %; mean (SD) | 31.4 | (3.0) | 34.5 | (2.7) | 0.006* |
| Platelet, × 104/μL; mean (SD) | 44.6 | (23.8) | 35.2 | (16.8) | 0.18 |
| T-bil, mg/L; mean (SD) | 0.7 | (3.7) | 0.4 | (1.3) | 0.48 |
| AST, IU/L; mean (SD) | 26.1 | (10.9) | 47.9 | (47.4) | 0.23 |
| ALT, IU/L; mean (SD) | 22.9 | (16.8) | 36.7 | (56.7) | 0.52 |
| Alb, g/L; mean (SD) | 3.6 | (0.3) | 3.9 | (0.4) | 0.03* |
| Na, mEq/L; mean (SD) | 136.6 | (3.2) | 136.7 | (2.0) | 0.90 |
| CRP, mg/dL; mean (SD) | 7.3 | (3.7) | 3.8 | (3.7) | 0.02* |
SD standard deviation, KD Kawasaki disease, *statistically significant defined as p <0.05